The latest headlines across every section, pulled from official and open-access sources.
Final Rule: Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans
The FDA has approved the sunscreen chemical bemotrizinol, a UV light filter that has been available in Europe, Asia, and Australia for more than 20 years. Health advocates and skin care industry groups alike are hopeful it can restore faith in sunscreen.
Statement from the American Diabetes Association Regarding 2026 Scientific Sessions mcarmody Wed, 06/10/2026 - 16:55 Official Statement Statement from the American Diabetes Association Regarding 2026 Scientific Sessions ARLINGTON, Va. June 10, 2026 Today, Charles "Chuck" Henderson, chief executive officer of the American Diabetes Association ® (ADA) issued a statement and apology reflecting on events that occurred during the ADA’s 2026 Scientific Sessions in New Orleans. The ADA is commissioning a thorough independent review of the events that occurred, and we remain committed to…
The FDA has approved changes to the Drugs Facts Label of the over-the-counter (OTC) weight loss drug, alli (orlistat) 60 mg capsules, to warn of risks of acute kidney injury, which is a rare side effect of the medication. The labeling now advises consumers to ask a health care provider before using
SBIA Learn offers a variety of multimedia resources to provide information that is comprehensive, interactive, and easily accessible to small pharmaceutical business and industry.
A Comprehensive Resource for Information on Human Drug Development in Regulation
This virtual training is designed to help staff at academic medical centers meet the federal requirements for registering clinical studies and reporting results on ClinicalTrials.gov.
Source: CureSearch for Children's Cancer Related MedlinePlus Pages: Neuroblastoma
Source: Children's Oncology Group Related MedlinePlus Pages: Cancer in Children
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.
The Food and Drug Administration (FDA) has approved changes to the Drugs Facts Label of the over-the-counter (OTC) weight loss drug, alli (orlistat) 60 mg capsules, to warn of risks of acute kidney injury, which is a rare side effect of the medication.
The next evolution of patient experience will not be defined by more digital touchpoints. It will be defined by giving nurses and care teams the capacity to be fully present. The post Restoring the Patient-Clinician Relationship to the Center of Care appeared first on MedCity News .
Source: Johns Hopkins Bloomberg School of Public Health - PDF Related MedlinePlus Pages: Biodefense and Bioterrorism , Poisoning
Prevention requires more than faster detection. Organizations need payment programs with end-to-end visibility and controls that intervene before losses occur. The post From Detection to Defense: Building Fraud-Resilient Healthcare Payment Systems appeared first on MedCity News .
[Sponsored] Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. The post The Healthcare Payments Industry Has a Perception Problem appeared first on MedCity News .
Healthcare needs systems that work for providers, for health plans, and most importantly, for patients. And that starts with designing not just for technology, but for the people who depend on it, people who need to trust it will work when it matters most. The post Healthcare IT Isn’t Broken — But How We Design It Might Be appeared first on MedCity News .
Latest information on cases including British nationals.
Presence of foreign substance: small metallic particles in chewable tablets. — Guardian Drug Co. Inc. · Class II · Ongoing
Lack of Assurance of Sterility — Spectra Medical Devices, Llc · Class II · Ongoing · 210625 ampules
Presence of foreign substance: small metallic particles in chewable tablets. — Guardian Drug Co. Inc. · Class II · Ongoing
Presence of foreign substance: small metallic particles in chewable tablets. — Guardian Drug Co. Inc. · Class II · Ongoing
Presence of foreign substance: small metallic particles in chewable tablets. — Guardian Drug Co. Inc. · Class II · Ongoing
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan — Eugia US LLC · Class III · Ongoing · 168,300 vials